EAS is advancing & exchanging knowledge concerning the causes, natural history, treatment & prevention of atherosclerotic disease. #EASCongress2026
Athens, Greece
Joined December 2010
- Tweets6K
- Following982
- Followers3.8K
- Likes3.7K
EAS Congress retweeted
Some congress moments stay with you. Presenting my SaaG poster at #EASCongress2026 on the intersection between reproductive planning and lipid management, and discussing it with Marianne Benn as moderator, was one of them. A real honour, and a very thoughtful exchange #MyEAS2026
EAS Congress retweeted
Very glad to 🗣️ Nick Nurmohamed’s work on inflam plaques during the EAS Research Grant Winners session. The question is no longer whether inflam matters in ath, but how we identify biologically active plaques and translate that into better clinical decisions. Great work, Nick! 👏
EAS Congress retweeted
The real value of a programme like this is not only what it gives you during the fellowship. It is what stays afterwards: a network, a sense of belonging, and the confidence to take your place in the scientific conversation #EASCongress2026 #MyEAS2026
That is why I was very happy to speak about the EAS Young Fellows Programme at #EASCongress2026.
For me, it has been much more than a fellowship: a place where ideas are challenged, collaborations start, and young researchers learn to contribute with confidence #MyEAS2026
EAS Congress retweeted
That is why I was very happy to speak about the EAS Young Fellows Programme at #EASCongress2026.
For me, it has been much more than a fellowship: a place where ideas are challenged, collaborations start, and young researchers learn to contribute with confidence #MyEAS2026
EAS Congress retweeted
My take 🏡 from the EAS Stage: Social media is not the opposite of serious medicine. Used responsibly, it helps scientific societies enter the space where opinions, doubts and decisions are formed. That is not marketing. That is prevention #EASCongress2026 #MyEAS2026 @society_eas
I was grateful to bring the Italian perspective to this EAS Stage discussion. Italy has key building blocks: governance, prevention networks, access pathways, monitoring and intensification. The next step is connection 🤝 #EASCongress2026 @society_eas @KatiOorni
EAS Congress retweeted
In prevention, the weakest point is often the drop off. Risk is identified, but the patient does not reach treatment. Treatment is started, but not intensified. Therapy is prescribed, but trust is missing. SAFE HEARTS needs to protect the whole chain #EASCongress2026 @society_eas
EAS Congress retweeted
This year's @EASCongress #2026 was phenomenal. Congratulations to @BNordestgaard, @ProfKausikRay and the whole team!
⚡ The Anistschkow Prize 2026 winner Prof Heribert Shunkert shared his decades of groundbreaking work in opening talk on "Interplay of #genetics and modifiable risk in #atherosclerosis"
⚡ Joint sessions of @nationallipid - #EAS and @escardio -#EAS were packed to capacity.
⚡ Best part, I got to meet and learn from my friends and thought leaders from around the world!
@drpablocorral @ErinMichos @DineshKalra @FedericaFogacci @skathire @CBallantyneMD @society_eas
See you all next year in #Gothenburg!
EAS Congress retweeted
The future #EASCongress2026
ANGPTL3 silencing is entering a very interesting space in lipid lowering. Preclinical and Phase 1 data on AZD1705, a liver targeted approach aiming to lower atherogenic lipoproteins
EAS Congress retweeted
Wonderful experience at #MyEAS2026 connecting with great leaders of the field and amazing people, top notch science in the beautiful city of Athens. Thank you for the memories
@EASCongress
@EugeniaGianos
@iuliaiatan
@ErinMichos
@marstonMD
Next up the #NLASessions2026 in Chicago. See you all there for more groundbreaking lipid science @nationallipid
EAS Congress retweeted
From vulnerable plaque to vulnerable patient.
Isabel Gonçalves’ 🆕 @ATHjournal review asks whether imaging + circulating markers can predict plaque vulnerability.
Catch her #EASCongress2026 plenary:
🕘 09:14 | Anitschkow Hall
🔗 atherosclerosis-journal.com/…
@EASCongress @society_eas
EAS Congress retweeted
Take-home from this keynote: ApoB is becoming more than a “better LDL marker”. It is a framework to integrate particle number, particle type, atherogenicity and biology.
ApoB 2026 is not only answers. It is better questions.
#EASCongress2026 #MyEAS2026
EAS Congress retweeted
Being a part of @society_eas Young Fellows Programme 2024-2026 is extremely important for me and I am deeply gratefull for this opportunity ❤️
EAS Congress retweeted
Adding Bempedoic acid to high potency statins and Ezetimibe gives significant reductions in LDL-chol in the Milos study and argues for a triple therapy combination treatment
From the real world MILOS study just presented
@EASCongress #milos @ProfKausikRay @LaleTokgozoglu
EAS Congress retweeted
Important takeaway from #EASCongress2026: the effect of triglyceride lowering on LDL-C depends on baseline TG levels.
Prof. Chris Packard shared key physiological insights showing why personalized lipid management remains essential for CVD prevention.
Great science #eas
EAS Congress retweeted
It’s great to see that in the era of novel pharmacotherapy #lifestyle approach is still acknowledged in terms of #lipid #disorders. Great summary, particularly of #diet by @ErinMichos at @EASCongress
#MyEAS2026
EAS Congress retweeted
Pooled results from CoralReef lipids and HeFH studies presented today by @AL_Catapano: Enlicitide led to a safe apoB ⬇️ overtime, up to 50% at 24 wks, almost 50% at 52 wks. Over 80% of pts attained apoB goals @society_eas #EASCongress2026
#prevention #pcsk9 #lipids #cholesterol
